OnCure Holdings, Inc. Agrees To Sell Its Businesses Through Chapter 11 Proceedings

OnCure Holdings, Inc. and certain of its affiliates, leading providers of management services and facilities to radiation oncology physician groups, previously announced an agreement in principle for the sale of its businesses.� OnCure is pleased to announce that it has entered into an investment agreement with Radiation Therapy Services, Inc. ("RTS") under which RTS has agreed to acquire OnCure for approximately $125 million, including $42.5 million in cash (plus covering certain expenses and subject to certain working capital adjustments) and up to $82.5 million in assumed debt.� In addition, OnCure's secured noteholders have executed a restructuring support agreement outlining their commitment to support the transaction with RTS.

On June 14, 2013, OnCure commenced reorganization cases under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.� With the execution of the investment agreement, RTS has agreed to be the lead bidder in a sale process to take place during the chapter 11 cases.� If RTS's bid is successful and receives Bankruptcy Court approval, the acquisition will be completed through OnCure's chapter 11 plan of reorganization, which is expected to occur prior to the end of October 2013.

On June 18, 2013, the Bankruptcy Court approved OnCure's $25 million debtor in possession credit facility on an interim basis and other relief related to the continued operation of its businesses.

OnCure's legal advisors in connection with its restructuring are Latham & Watkins LLP and Richards, Layton & Finger, P.A.� Financial advisory services are being provided by Jefferies LLC. Match Point Partners LLC is providing management services to OnCure.

For more information on OnCure, please visit www.oncure.com.� For more information on OnCure's bankruptcy case, please visit www.kccllc.net/oncure, email OnCureInfo@kccllc.com, or call the case-dedicated toll-free phone number at (877) 634-7166.

SOURCE OnCure Holdings, Inc.

Latest Press Release on Corporate News

Cority Welcomes New CFO and CMO

TORONTO, March 13, 2025 (GLOBE NEWSWIRE) -- Cority, the global leader in enterprise Environmental, Health, and Safety (EHS) and Sustainability software, announced the appointment of ...

Curia Announces Strategic Refinancing to Support Continued Growth

ALBANY, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced it has refinance...

BNCT Market Booms with 38.7% CAGR - A Game-Changer in Cancer Treatment | Valuates Reports

PR Newswire BANGALORE, India, Feb. 28, 2025 Boron Neutron Capture Therapy (BNCT) Market is Segmented by Type (Thermal Beam, Epithermal Beam), by Application (Brain Tumor, Extracrania...

Disposable Gloves Market Size to Reach a Value of US$17.66 Billion by 2031, The Insight Partners

PR Newswire NEW YORK, Feb. 28, 2025 NEW YORK, Feb. 28, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the disposable gloves market share is e...

Bacterial Vaginosis Drug Market to Surge to $3.82 Billion by 2031, Fuelled by Growing Awareness and Treatment Innovation | Exclusive Report by The Insight Partners

PR Newswire NEW YORK, Feb. 27, 2025 The bacterial vaginosis drug market is observing significant growth due to the rising prevalence of bacterial vaginosis and the increased focus on...